Effects of unilateral 6-hydroxydopamine lesions on neuropeptide immunoreactivity in the basal ganglia of the common marmoset, Callithrix jacchus, a quantitative immunohistochemical analysis-Reference-Cited by-同舟云学术

Effects of unilateral 6-hydroxydopamine lesions on neuropeptide immunoreactivity in the basal ganglia of the common marmoset, Callithrix jacchus, a quantitative immunohistochemical analysis

Published:1995-10 Issue:3 Volume:9 Page:155-164
ISSN:0891-0618
Container-title:Journal of Chemical Neuroanatomy
language:en
Short-container-title:Journal of Chemical Neuroanatomy

Author:

Roeling T.A.P.,Docter G.J.,Voorn P.,Melchers B.P.C.,Wolters E.Ch.,Groenewegen H.J.

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience

Reference41 articles.

1. Peptides and Parkinson's disease;Agid;Trends Neurosei.,1985

2. Functional architecture of basal ganglia circuits: neural substrates of parallel processing;Alexander;Trends Neurosd,1990

3. Neuropeptides and dopamine in the marmoset: effect of treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): an animal model for Parkinson's disease?;Allen;Brain,1986

4. Motor impairments and neurochemical changes after unilateral 6-hydroxydopamine lesion of the nigrostriatal dopaminergie system in monkeys;Apicella;Neuroscience,1990

5. Experimental torticollis in the monkey produced by unilateral 6-hydroxydopamine brain lesions;Crossman;Brain Res.,1978

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a DSM test battery to determine depression-like marmoset;2024-07-11

2. A Review on Neurodegenerative Diseases with their Suitable Animal Models;Biosciences Biotechnology Research Asia;2022-09-29

3. Curcuma longa extract ameliorates motor and cognitive deficits of 6-hydroxydopamine-infused Parkinson’s disease model rats;Advances in Traditional Medicine;2021-09-12

4. Generation of Mitochondrial Toxin Rodent Models of Parkinson’s Disease Using 6-OHDA, MPTP, and;Methods in Molecular Biology;2021

5. In vivo, in vitro and pharmacologic models of Parkinson's disease;Physiological Research;2019-02-28